AL
ECL icon

Aspiriant LLC’s Ecolab ECL Stock Holding History

Aspiriant LLC’s Portfolio ECL Stock Details ECL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$465K Buy
1,670
+169
+11% +$44.5K 0.01% 257
2026
Q1 		$399K Sell
1,501
-11
-0.7% -$3.1K 0.01% 247
2025
Q4 		$397K Buy
1,512
+12
+0.8% +$3.2K 0.01% 242
2025
Q3 		$411K Sell
1,500
-291
-16% -$79K 0.01% 217
2025
Q2 		$483K Buy
1,791
+272
+18% +$69.1K 0.02% 202
2025
Q1 		$385K Buy
1,519
+17
+1% +$4.29K 0.01% 212
2024
Q4 		$352K Buy
1,502
+1
+0.1% +$249 0.01% 222
2024
Q3 		$383K Hold
1,501
– – 0.01% 209
2024
Q2 		$357K Sell
1,501
-112
-7% -$25.9K 0.01% 214
2024
Q1 		$372K Sell
1,613
-13
-0.8% -$2.76K 0.02% 228
2023
Q4 		$323K Buy
1,626
+43
+3% +$7.73K 0.01% 229
2023
Q3 		$268K Buy
1,583
+31
+2% +$5.64K 0.01% 239
2023
Q2 		$290K Hold
1,552
– – 0.01% 228
2023
Q1 		$257K Hold
1,552
– – 0.01% 237
2022
Q4 		$226K Buy
1,552
+52
+3% +$7.64K 0.01% 246
2022
Q3 		$217K Sell
1,500
-23
-2% -$3.73K 0.01% 242
2022
Q2 		$235K Buy
1,523
+1
+0.1% +$166 0.01% 241
2022
Q1 		$269K Sell
1,522
-4
-0.3% -$751 0.01% 235
2021
Q4 		$358K Buy
1,526
+20
+1% +$4.52K 0.02% 211
2021
Q3 		$314K Buy
1,506
+1
+0.1% +$219 0.02% 192
2021
Q2 		$310K Buy
1,505
+5
+0.3% +$1.09K 0.02% 197
2021
Q1 		$321K Sell
1,500
-7
-0.5% -$1.49K 0.02% 174
2020
Q4 		$327K Sell
1,507
-4
-0.3% -$836 0.02% 166
2020
Q3 		$302K Buy
1,511
+11
+0.7% +$2.2K 0.02% 181
2020
Q2 		$298K Buy
+1,500
New +$290K 0.03% 155

Other funds holding ECL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Gates Foundation Trust
Gates Foundation Trust Kirkland, Washington $34.4B AUM 26.34% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Aspiriant LLC's ECL Position: Q2 2026 in Review

Aspiriant LLC increased its Ecolab (ECL) stake by 11% in Q2 2026, buying an estimated $44.5K and bringing the position to 1,670 shares worth $465K. The position accounts for 0.01% of the portfolio, ranked #257.

Aspiriant LLC first reported a position in ECL in Q2 2020 and has held it in 25 quarters since. The position peaked at $483K in Q2 2025. 1,710 funds tracked by Wall St. Rank hold ECL as of Q2 2026.

  • Aspiriant LLC held 1,670 shares of Ecolab worth $465K as of Q2 2026.
  • Aspiriant LLC bought 169 Ecolab shares in Q2 2026, an estimated $44.5K.
  • Ecolab made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #257 holding.
  • Aspiriant LLC first reported a position in Ecolab in Q2 2020 and has held it in 25 quarters since.
  • Aspiriant LLC's Ecolab position peaked at $483K in Q2 2025.
  • 1,710 funds tracked by Wall St. Rank held Ecolab as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.